Analytical testing, QC

CRO ‘adding expertise’ to respond to the evolution of biometrics

06-Feb-2020 By Vassia Barba

Acquisition of Clindata’s human health biometrics division is expected to increase Synteract’s geographical footprint along with the adaptability of its biometrics services solutions.

Vetter consolidates development labs in one location

04-Feb-2020 By Ben Hargreaves

Vetter decides to house its development laboratories together in Ravensburg, Germany, to modernize capabilities, with plans for further expansion.

CROs partner on joint discovery platform to accelerate R&D projects

04-Feb-2020 By Vassia Barba

Leveraging Eurofins’ pharmacology, in-vitro models and ADME capabilities, PharmaResources aims to accelerate drug discovery for its clients in small molecule drug R&D.

FDA puts spotlight on compounded drugs, opens educational center

07-Jan-2020 By Vassia Barba

In an aim to improve quality assurance and control of compounded medicine, the US FDA opens a Compounding Quality Center of Excellence.

Combined in-vivo and in-vitro capabilities for faster efficacy assessment

23-Dec-2019 By Vassia Barba

Amylgen and Neuron-Experts partner to create a comprehensive offering of in-vivo and in-vitro efficacy evaluation for compounds in neurodegenerative diseases.

Metrion and LifeArc extend collaboration on neurological target

17-Dec-2019 By Vassia Barba

After one year of collaborative work, Metrion and LifeArc agree to continue research on a joint project focused on neuroscience ion channel drug discovery for another year.

Thermo Fisher expands site, boosts biologics processing offering

28-Nov-2019 By Vassia Barba

Thermo Fisher Scientific doubles the capacity of its gene therapy and viral vector processing facility in Alachua, Florida, to provide scalability to customers.

GHO raises €975M for more European contract service buyouts

26-Nov-2019 By Nick Taylor

GHO Capital Partners raises €975m European healthcare fund to place another set of bets on contract service providers.

Fujifilm expands gene therapy analytical services with $55m lab

21-Nov-2019 By Vassia Barba

Fujifilm Diosynth opens a 60,000-square-feet Gene Therapy Innovation Center to support upstream, downstream and analytical development services.

CPhI Worldwide 2019

Early monitoring key to countering variability in bioproduction

14-Nov-2019 By Vassia Barba

Regardless of the quality of the raw materials used in bioproduction processes, variability is a very common threat that can be addressed, says Thermo Fisher executive.

Mesa Labs in $180m Gyros acquisition for biopharma asset development

12-Nov-2019 By Ben Hargreaves

Mesa Labs buys Gyros to gain access to the latter’s capabilities in the discovery, development and manufacture of biotherapeutics.

People on the Move: Outsourcing-Pharma roundup October ‘19

01-Nov-2019 By Melissa Fassbender

This month’s people on the move includes a new therapeutic lead at Advanced Clinical, with plans to create a network of investigation sites, as well as CEOs at AIT Bioscience and Pharm-Olam, who discuss plans for moving forward.

Eurofins to support San Diego-based incubator

31-Oct-2019 By Melissa Fassbender

Eurofins Discovery has signed a Founding Partner sponsorship agreement with BioLabs San Diego, a membership-based network of shared lab facilities.

HistoIndex expands AI-based digital pathology platform

31-Oct-2019 By Melissa Fassbender

The Singapore-based company recently expanded its AI-based digital pathology platform to support preclinical discovery and drug development programs.

GE Healthcare sets up UK biotech R&D lab

24-Oct-2019 By Vassia Barba

GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.